ID   LMAN1_HUMAN             Reviewed;         510 AA.
AC   P49257; Q12895; Q8N5I7; Q9UQG1; Q9UQG2; Q9UQG3; Q9UQG4; Q9UQG5;
AC   Q9UQG6; Q9UQG7; Q9UQG8; Q9UQG9; Q9UQH0; Q9UQH1; Q9UQH2;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-2002, sequence version 2.
DT   21-MAR-2012, entry version 123.
DE   RecName: Full=Protein ERGIC-53;
DE   AltName: Full=ER-Golgi intermediate compartment 53 kDa protein;
DE   AltName: Full=Gp58;
DE   AltName: Full=Intracellular mannose-specific lectin MR60;
DE   AltName: Full=Lectin mannose-binding 1;
DE   Flags: Precursor;
GN   Name=LMAN1; Synonyms=ERGIC53, F5F8D;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 31-59 AND 418-432.
RC   TISSUE=Liver, and Placenta;
RX   MEDLINE=94039195; PubMed=8223692;
RA   Schindler R., Itin C., Zerial M., Lottspeich F., Hauri H.-P.;
RT   "ERGIC-53, a membrane protein of the ER-Golgi intermediate
RT   compartment, carries an ER retention motif.";
RL   Eur. J. Cell Biol. 61:1-9(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 31-41.
RC   TISSUE=Peripheral blood;
RX   MEDLINE=95181303; PubMed=7876089; DOI=10.1074/jbc.270.8.3551;
RA   Arar C., Carpentier V., Le Caer J.-P., Monsigny M., Legrand A.,
RA   Roche A.-C.;
RT   "ERGIC-53, a membrane protein of the endoplasmic reticulum-Golgi
RT   intermediate compartment, is identical to MR60, an intracellular
RT   mannose-specific lectin of myelomonocytic cells.";
RL   J. Biol. Chem. 270:3551-3553(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS GLN-14; ALA-39 AND
RP   LEU-410, AND INVOLVEMENT IN F5F8D1.
RX   MEDLINE=99192442; PubMed=10090935;
RA   Nichols W.C., Terry V.H., Wheatley M.A., Yang A., Zivelin A.,
RA   Ciavarella N., Stefanile C., Matsushita T., Saito H., de Bosch N.B.,
RA   Ruiz-Saez A., Torres A., Thompson A.R., Feinstein D.I., White G.C.,
RA   Negrier C., Vinciguerra C., Aktan M., Kaufman R.J., Ginsburg D.,
RA   Seligsohn U.;
RT   "ERGIC-53 gene structure and mutation analysis in 19 combined factors
RT   V and VIII deficiency families.";
RL   Blood 93:2261-2266(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT LEU-410.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 31-44.
RC   TISSUE=Platelet;
RX   MEDLINE=22608298; PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [6]
RP   SIMILARITY TO LEGUMINOUS LECTINS.
RX   MEDLINE=94265253; PubMed=8205612; DOI=10.1016/0092-8674(94)90047-7;
RA   Fiedler K., Simons K.;
RT   "A putative novel class of animal lectins in the secretory pathway
RT   homologous to leguminous lectins.";
RL   Cell 77:625-626(1994).
RN   [7]
RP   MASS SPECTROMETRY.
RC   TISSUE=Mammary cancer;
RX   MEDLINE=21829512; PubMed=11840567;
RX   DOI=10.1002/1615-9861(200202)2:2<212::AID-PROT212>3.0.CO;2-H;
RA   Harris R.A., Yang A., Stein R.C., Lucy K., Brusten L., Herath A.,
RA   Parekh R., Waterfield M.D., O'Hare M.J., Neville M.A., Page M.J.,
RA   Zvelebil M.J.;
RT   "Cluster analysis of an extensive human breast cancer cell line
RT   protein expression map database.";
RL   Proteomics 2:212-223(2002).
RN   [8]
RP   FUNCTION, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, MOTIF ER EXPORT,
RP   AND DISULFIDE BOND.
RX   PubMed=13130098; DOI=10.1242/jcs.00759;
RA   Nufer O., Kappeler F., Guldbrandsen S., Hauri H.-P.;
RT   "ER export of ERGIC-53 is controlled by cooperation of targeting
RT   determinants in all three of its domains.";
RL   J. Cell Sci. 116:4429-4440(2003).
RN   [9]
RP   INTERACTION WITH MCFD2, AND FUNCTION.
RX   PubMed=12717434; DOI=10.1038/ng1153;
RA   Zhang B., Cunningham M.A., Nichols W.C., Bernat J.A., Seligsohn U.,
RA   Pipe S.W., McVey J.H., Schulte-Overberg U., de Bosch N.B.,
RA   Ruiz-Saez A., White G.C., Tuddenham E.G., Kaufman R.J., Ginsburg D.;
RT   "Bleeding due to disruption of a cargo-specific ER-to-Golgi transport
RT   complex.";
RL   Nat. Genet. 34:220-225(2003).
RN   [10]
RP   SUBCELLULAR LOCATION, SUBUNIT, AND INTERCHAIN DISULFIDE BONDS.
RX   PubMed=16257008; DOI=10.1016/j.jmb.2005.09.077;
RA   Neve E.P., Lahtinen U., Pettersson R.F.;
RT   "Oligomerization and interacellular localization of the glycoprotein
RT   receptor ERGIC-53 is independent of disulfide bonds.";
RL   J. Mol. Biol. 354:556-568(2005).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) OF 32-277 IN COMPLEX WITH MCFD2
RP   AND CALCIUM IONS, SUBUNIT, AND DISULFIDE BOND.
RX   PubMed=20138881; DOI=10.1016/j.febslet.2010.02.009;
RA   Wigren E., Bourhis J.M., Kursula I., Guy J.E., Lindqvist Y.;
RT   "Crystal structure of the LMAN1-CRD/MCFD2 transport receptor complex
RT   provides insight into combined deficiency of factor V and factor
RT   VIII.";
RL   FEBS Lett. 584:878-882(2010).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.84 ANGSTROMS) OF 31-285 IN COMPLEX WITH
RP   CALCIUM IONS, SUBUNIT, AND DISULFIDE BOND.
RX   PubMed=20142513; DOI=10.1073/pnas.0908526107;
RA   Nishio M., Kamiya Y., Mizushima T., Wakatsuki S., Sasakawa H.,
RA   Yamamoto K., Uchiyama S., Noda M., McKay A.R., Fukui K., Hauri H.P.,
RA   Kato K.;
RT   "Structural basis for the cooperative interplay between the two
RT   causative gene products of combined factor V and factor VIII
RT   deficiency.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:4034-4039(2010).
CC   -!- FUNCTION: Mannose-specific lectin. May recognize sugar residues of
CC       glycoproteins, glycolipids, or glycosylphosphatidyl inositol
CC       anchors and may be involved in the sorting or recycling of
CC       proteins, lipids, or both. The LMAN1-MCFD2 complex forms a
CC       specific cargo receptor for the ER-to-Golgi transport of selected
CC       proteins.
CC   -!- SUBUNIT: Exists both as a covalent disulfide-linked homohexamer,
CC       and a complex of three disulfide-linked dimers non-covalently kept
CC       together. Interacts with MCFD2.
CC   -!- INTERACTION:
CC       O15260:SURF4; NbExp=3; IntAct=EBI-1057738, EBI-1044848;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum-Golgi intermediate
CC       compartment membrane; Single-pass type I membrane protein. Golgi
CC       apparatus membrane; Single-pass membrane protein. Endoplasmic
CC       reticulum membrane; Single-pass type I membrane protein.
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DOMAIN: The FF ER export motif at the C-terminus is not sufficient
CC       to support endoplasmic reticulum exit, and needs assistance of
CC       Gln-501 for proper recognition of COPII coat components.
CC   -!- PTM: The N-terminal may be partly blocked.
CC   -!- MASS SPECTROMETRY: Mass=54222.91; Method=MALDI; Range=31-510;
CC       Source=PubMed:11840567;
CC   -!- DISEASE: Defects in LMAN1 are THE cause of factor V and factor
CC       VIII combined deficiency type 1 (F5F8D1) [MIM:227300]; also known
CC       as multiple coagulation factor deficiency I (MCFD1). F5F8D1 is an
CC       autosomal recessive blood coagulation disorder characterized by
CC       bleeding symptoms similar to those in hemophilia or
CC       parahemophilia, that are caused by single deficiency of FV or
CC       FVIII, respectively. The most common symptoms are epistaxis,
CC       menorrhagia, and excessive bleeding during or after trauma. Plasma
CC       levels of coagulation factors V and VIII are in the range of 5 to
CC       30% of normal.
CC   -!- SIMILARITY: Contains 1 L-type lectin-like domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X71661; CAA50653.1; -; mRNA.
DR   EMBL; U09716; AAA95960.1; -; mRNA.
DR   EMBL; AF081866; AAD32479.1; -; Genomic_DNA.
DR   EMBL; AF081865; AAD32479.1; JOINED; Genomic_DNA.
DR   EMBL; AF081867; AAD32480.1; -; Genomic_DNA.
DR   EMBL; AF081869; AAD32481.1; -; Genomic_DNA.
DR   EMBL; AF081868; AAD32481.1; JOINED; Genomic_DNA.
DR   EMBL; AF081871; AAD32482.1; -; Genomic_DNA.
DR   EMBL; AF081870; AAD32482.1; JOINED; Genomic_DNA.
DR   EMBL; AF081873; AAD32483.1; -; Genomic_DNA.
DR   EMBL; AF081872; AAD32483.1; JOINED; Genomic_DNA.
DR   EMBL; AF081875; AAD32484.1; -; Genomic_DNA.
DR   EMBL; AF081874; AAD32484.1; JOINED; Genomic_DNA.
DR   EMBL; AF081877; AAD32485.1; -; Genomic_DNA.
DR   EMBL; AF081876; AAD32485.1; JOINED; Genomic_DNA.
DR   EMBL; AF081879; AAD32486.1; -; Genomic_DNA.
DR   EMBL; AF081878; AAD32486.1; JOINED; Genomic_DNA.
DR   EMBL; AF081880; AAD32487.1; -; Genomic_DNA.
DR   EMBL; AF081882; AAD32488.1; -; Genomic_DNA.
DR   EMBL; AF081881; AAD32488.1; JOINED; Genomic_DNA.
DR   EMBL; AF081884; AAD32489.1; -; Genomic_DNA.
DR   EMBL; AF081883; AAD32489.1; JOINED; Genomic_DNA.
DR   EMBL; AF081885; AAD32490.1; -; Genomic_DNA.
DR   EMBL; BC032330; AAH32330.1; -; mRNA.
DR   IPI; IPI00026530; -.
DR   PIR; S42626; S42626.
DR   RefSeq; NP_005561.1; NM_005570.3.
DR   UniGene; Hs.465295; -.
DR   PDB; 3A4U; X-ray; 1.84 A; A=31-285.
DR   PDB; 3LCP; X-ray; 2.45 A; A/B=32-277.
DR   PDBsum; 3A4U; -.
DR   PDBsum; 3LCP; -.
DR   ProteinModelPortal; P49257; -.
DR   SMR; P49257; 37-269.
DR   IntAct; P49257; 3.
DR   MINT; MINT-4999949; -.
DR   STRING; P49257; -.
DR   PhosphoSite; P49257; -.
DR   DMDM; 22261801; -.
DR   PeptideAtlas; P49257; -.
DR   PRIDE; P49257; -.
DR   DNASU; 3998; -.
DR   Ensembl; ENST00000251047; ENSP00000251047; ENSG00000074695.
DR   GeneID; 3998; -.
DR   KEGG; hsa:3998; -.
DR   UCSC; uc002lhz.1; human.
DR   CTD; 3998; -.
DR   GeneCards; GC18M056969; -.
DR   H-InvDB; HIX0014483; -.
DR   HGNC; HGNC:6631; LMAN1.
DR   HPA; HPA002320; -.
DR   MIM; 227300; phenotype.
DR   MIM; 601567; gene.
DR   neXtProt; NX_P49257; -.
DR   Orphanet; 35909; Combined deficiency of factor V and factor VIII.
DR   PharmGKB; PA30399; -.
DR   eggNOG; NOG292314; -.
DR   GeneTree; ENSGT00530000062977; -.
DR   HOVERGEN; HBG052332; -.
DR   InParanoid; P49257; -.
DR   KO; K10080; -.
DR   OMA; GTVPFWA; -.
DR   OrthoDB; EOG4NCMCM; -.
DR   PhylomeDB; P49257; -.
DR   Reactome; REACT_17015; Metabolism of proteins.
DR   DrugBank; DB00025; Antihemophilic Factor.
DR   NextBio; 15688; -.
DR   ArrayExpress; P49257; -.
DR   Bgee; P49257; -.
DR   Genevestigator; P49257; -.
DR   GermOnline; ENSG00000074695; Homo sapiens.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:ProtInc.
DR   GO; GO:0033116; C:endoplasmic reticulum-Golgi intermediate compartment membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:ProtInc.
DR   GO; GO:0016021; C:integral to membrane; TAS:ProtInc.
DR   GO; GO:0005537; F:mannose binding; TAS:ProtInc.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0051082; F:unfolded protein binding; TAS:ProtInc.
DR   GO; GO:0007596; P:blood coagulation; TAS:ProtInc.
DR   GO; GO:0006888; P:ER to Golgi vesicle-mediated transport; TAS:ProtInc.
DR   GO; GO:0007030; P:Golgi organization; IMP:UniProtKB.
DR   GO; GO:0010638; P:positive regulation of organelle organization; IMP:UniProtKB.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0006457; P:protein folding; TAS:ProtInc.
DR   GO; GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   InterPro; IPR008985; ConA-like_lec_gl.
DR   InterPro; IPR013320; ConA-like_subgrp.
DR   InterPro; IPR005052; Lectin_leg.
DR   Gene3D; G3DSA:2.60.120.200; ConA_like_subgrp; 1.
DR   PANTHER; PTHR12223; Lectin_leg; 1.
DR   Pfam; PF03388; Lectin_leg-like; 1.
DR   SUPFAM; SSF49899; ConA_like_lec_gl; 1.
DR   PROSITE; PS51328; L_LECTIN_LIKE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Disulfide bond; Endoplasmic reticulum; ER-Golgi transport;
KW   Golgi apparatus; Lectin; Membrane; Metal-binding; Polymorphism;
KW   Protein transport; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     30
FT   CHAIN        31    510       Protein ERGIC-53.
FT                                /FTId=PRO_0000017660.
FT   TOPO_DOM     31    477       Lumenal (Potential).
FT   TRANSMEM    478    498       Helical; (Potential).
FT   TOPO_DOM    499    510       Cytoplasmic (Potential).
FT   DOMAIN       44    267       L-type lectin-like.
FT   REGION      251    253       Carbohydrate binding (By similarity).
FT   MOTIF       509    510       ER export motif.
FT   METAL       152    152       Calcium.
FT   METAL       154    154       Calcium; via carbonyl oxygen.
FT   METAL       156    156       Calcium.
FT   METAL       181    181       Calcium.
FT   BINDING      88     88       Carbohydrate (By similarity).
FT   BINDING     121    121       Carbohydrate (By similarity).
FT   BINDING     156    156       Carbohydrate (By similarity).
FT   BINDING     178    178       Carbohydrate (By similarity).
FT   SITE        501    501       Required for ER export.
FT   DISULFID    190    230
FT   DISULFID    466    466       Interchain.
FT   DISULFID    475    475       Interchain.
FT   VARIANT      14     14       R -> Q (in dbSNP:rs1043302).
FT                                /FTId=VAR_013703.
FT   VARIANT      39     39       V -> A (in dbSNP:rs33926449).
FT                                /FTId=VAR_013704.
FT   VARIANT     355    355       I -> T (in dbSNP:rs3737392).
FT                                /FTId=VAR_049770.
FT   VARIANT     410    410       M -> L (in dbSNP:rs2298711).
FT                                /FTId=VAR_013705.
FT   CONFLICT    153    153       S -> T (in Ref. 1; CAA50653).
FT   STRAND       43     46
FT   HELIX        48     50
FT   STRAND       67     69
FT   STRAND       80     83
FT   STRAND       93     97
FT   STRAND      102    113
FT   STRAND      150    152
FT   STRAND      163    167
FT   HELIX       178    180
FT   STRAND      187    191
FT   STRAND      201    208
FT   STRAND      211    217
FT   STRAND      228    235
FT   STRAND      256    268
SQ   SEQUENCE   510 AA;  57549 MW;  B87EF117C0CD386C CRC64;
     MAGSRQRGLR ARVRPLFCAL LLSLGRFVRG DGVGGDPAVA LPHRRFEYKY SFKGPHLVQS
     DGTVPFWAHA GNAIPSSDQI RVAPSLKSQR GSVWTKTKAA FENWEVEVTF RVTGRGRIGA
     DGLAIWYAEN QGLEGPVFGS ADLWNGVGIF FDSFDNDGKK NNPAIVIIGN NGQIHYDHQN
     DGASQALASC QRDFRNKPYP VRAKITYYQN TLTVMINNGF TPDKNDYEFC AKVENMIIPA
     QGHFGISAAT GGLADDHDVL SFLTFQLTEP GKEPPTPDKE ISEKEKEKYQ EEFEHFQQEL
     DKKKEEFQKG HPDLQGQPAE EIFESVGDRE LRQVFEGQNR IHLEIKQLNR QLDMILDEQR
     RYVSSLTEEI SKRGAGMPGQ HGQITQQELD TVVKTQHEIL RQVNEMKNSM SETVRLVSGM
     QHPGSAGGVY ETTQHFIDIK EHLHIVKRDI DNLVQRNMPS NEKPKCPELP PFPSCLSTVH
     FIIFVVVQTV LFIGYIMYRS QQEAAAKKFF
//
